BILL vs EBS
Bill Com Holdings Inc (BILL) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BILL revenue for 2025-06-30 was $1.46B. Net income was $23.8M. Revenue was up 13.4% from 2024-06-30 to 2025-06-30. BILL currently screens at market cap $4.78B.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
BILL currently screens at market cap $4.78B. EBS currently screens at market cap $416.4M.
Not investment advice. Open the BILL and EBS stock pages for the full models.
Not investment advice.